ADVERTISEMENT

Zydus Lifesciences - Efforts Underway To Improve Growth Prospects For Key Markets: Motilal Oswal

After acquiring Liqmeds and securing approval for niche products such as Sitagliptin, g-Vascepa, transdermals, etc. Zydus Lifesciences possesses an interesting product pipeline

<div class="paragraphs"><p>Close up tablets arranged for photograph. (Source: pxhere)</p></div>
Close up tablets arranged for photograph. (Source: pxhere)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More